الإحصائيات الأساسية
| CIK | 1814287 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Abacus Global Management, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| August 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-39403 Abacus Global Management, Inc. (Exact name of registrant as specif |
|
| August 14, 2025 |
abllw-form25 |
|
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001 |
|
| August 12, 2025 |
Abacus Global Management, Inc. Subsidiaries of Registrant The following is a list of Abacus Global Management, Inc. subsidiaries, excluding insignificant subsidiaries in the aggregate. Subsidiaries State or Other Jurisdiction of Incorporation or Organization Longevity Market Assets, LLC Entity also does business under the name: •ABL Tech •ABL Technologies Delaware Abacus Settlements, LLC Entity al |
|
| August 8, 2025 |
ex991-ablq22025earningsr Abacus Global Management Reports Second Quarter 2025 Results August 7, 2025 8:15 PM EDT - Second Quarter 2025 Total Revenue Nearly Doubles Year-over-Year to $56. |
|
| August 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00 |
|
| July 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001 |
|
| July 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001 |
|
| July 31, 2025 |
Abacus Global Management Announces Successful Completion of Exchange Offer and Consent Solicitation Exhibit 99.1 Abacus Global Management Announces Successful Completion of Exchange Offer and Consent Solicitation July 30, 2025 ORLANDO, Fla., July 30, 2025 (GLOBE NEWSWIRE) - Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced the completion of its previously announced exchange offer (the “Offer”) and consent |
|
| July 30, 2025 |
Abacus Global Management Announces Successful Warrant Exchange Offer Exhibit 99.1 Abacus Global Management Announces Successful Warrant Exchange Offer ORLANDO, Fla., July 30, 2025 (GLOBE NEWSWIRE) – Abacus Global Management, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leader in the alternative asset management space, today announced the expiration and results of its previously announced exchange offer (the “Offer”) and consent solicitation (the “Consent Solic |
|
| July 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001 |
|
| July 30, 2025 |
AMENDMENT NO. 1 TO WARRANT AGREEMENT Exhibit 10.1 AMENDMENT NO. 1 TO WARRANT AGREEMENT This amendment (this “Amendment”) is made as of July 30, 2025, by and between Abacus Global Management, Inc. (f/k/a Abacus Life, Inc.), a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (the “Warrant Agent”), and constitutes an amendment to that certain |
|
| July 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001 |
|
| July 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2) Abacus Global Management, Inc. (Name of Subject Company and Filing Person (Issuer)) Warrants to Acquire Shares of Common Stock 00258Y112 (Title of Class of Securities) (CUSIP Number of |
|
| July 29, 2025 |
TABLE OF CONTENTS Filed pursuant to Rule 424(b)(3) Registration No. 333-288412 Abacus Global Management, Inc. Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER PERIOD (AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTERN TIME, ON JULY |
|
| July 15, 2025 |
Exhibit 99.1 LETTER OF TRANSMITTAL AND CONSENT Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTERN TIME, ON JULY 29, 2025, OR SUCH LATER TIME AND DATE TO |
|
| July 15, 2025 |
Exhibit 99.4 LETTER TO CLIENTS OF BROKERS, DEALERS, COMMERCIAL BANKS, TRUST COMPANIES, AND OTHER NOMINEES Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EAS |
|
| July 15, 2025 |
As filed with the U.S. Securities and Exchange Commission on July 15, 2025. TABLE OF CONTENTS As filed with the U.S. Securities and Exchange Commission on July 15, 2025. Registration No. 333-288412 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware 6282 |
|
| July 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1) Abacus Global Management, Inc. (Name of Subject Company and Filing Person (Issuer)) Warrants to Acquire Shares of Common Stock 00258Y112 (Title of Class of Securities) (CUSIP Number of |
|
| July 15, 2025 |
Exhibit 99.3 LETTER TO BROKERS, DEALERS, COMMERCIAL BANKS, TRUST COMPANIES, AND OTHER NOMINEES Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTERN TIME, |
|
| July 15, 2025 |
Exhibit 10.23 Dealer Manager Agreement July 15, 2025 SG Americas Securities, LLC 245 Park Avenue New York, New York 10167 Ladies and Gentlemen: Abacus Global Management, Inc., a corporation organized under the laws of Delaware (the “Company” or “we”), has initiated an exchange offer (together with any amendments, supplements or extensions thereof, the “Exchange Offer”) to exchange the Company’s ou |
|
| June 30, 2025 |
Form of Tender and Support Agreement by and among the Company and the warrant holders party thereto. TENDER AND SUPPORT AGREEMENT This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of June , 2025, is entered into by and among Abacus Global Management, Inc. |
|
| June 30, 2025 |
Abacus Global Management Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants June 30, 2025 ORLANDO, Fla. |
|
| June 30, 2025 |
Form of Letter to Brokers, Dealers, Commercial Banks, Trust Companies, and Other Nominees. Exhibit 99.3 LETTER TO BROKERS, DEALERS, COMMERCIAL BANKS, TRUST COMPANIES, AND OTHER NOMINEES Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTERN TIME, ON |
|
| June 30, 2025 |
Exhibit 107 Calculation of Filing Fee Table Form S-4 (Form Type) Abacus Global Management, Inc. |
|
| June 30, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001 |
|
| June 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001 |
|
| June 30, 2025 |
Abacus Global Management Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants June 30, 2025 ORLANDO, Fla. |
|
| June 30, 2025 |
Exhibit 107 Calculation of Filing Fee Table SC TO-I (Form Type) Abacus Global Management, Inc. |
|
| June 30, 2025 |
Exhibit 99.4 LETTER TO CLIENTS OF BROKERS, DEALERS, COMMERCIAL BANKS, TRUST COMPANIES, AND OTHER NOMINEES Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTE |
|
| June 30, 2025 |
Form of Letter of Transmittal and Consent. Exhibit 99.1 LETTER OF TRANSMITTAL AND CONSENT Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTERN TIME, ON JULY 29, 2025, OR SUCH LATER TIME AND DATE TO W |
|
| June 30, 2025 |
Form of Notice of Guaranteed Delivery. Exhibit 99.2 NOTICE OF GUARANTEED DELIVERY OF WARRANTS OF ABACUS GLOBAL MANAGEMENT, INC Pursuant to the Prospectus/Offer to Exchange dated June 30, 2025 Instructions for Use Unless defined herein, terms used in this notice of guaranteed delivery (this “Notice of Guaranteed Delivery”) shall have the definitions set forth in the prospectus/offer to exchange, dated June 30, 2025 (as amended or supple |
|
| June 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Global Management, Inc. (Name of Subject Company and Filing Person (Issuer)) Warrants to Acquire Shares of Common Stock (Title of Class of Securities) 00258Y112 (CUSIP Number of Class of Securities) Jay J. Jackso |
|
| June 30, 2025 |
As filed with the U.S. Securities and Exchange Commission on June 30, 2025. As filed with the U.S. Securities and Exchange Commission on June 30, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware 6282 85-1210472 (State or other jurisdiction of incorporation or organ |
|
| June 27, 2025 |
Abacus Global Management Announces Intention to Conduct Exchange Offer and Consent Solicitation Relating to Warrants June 27, 2025 ORLANDO, Fla. |
|
| June 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001 |
|
| June 27, 2025 |
Abacus Global Management Announces Intention to Conduct Exchange Offer and Consent Solicitation Relating to Warrants June 27, 2025 ORLANDO, Fla. |
|
| June 27, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001 |
|
| June 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001 |
|
| June 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001- |
|
| May 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-3 |
|
| May 8, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-3 |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00 |
|
| May 8, 2025 |
ABACUS GLOBAL MANAGEMENT REPORTS FIRST QUARTER 2025 RESULTS - First Quarter 2025 Total Revenue More Than Doubled Year-over-Year to $44. |
|
| April 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6( |
|
| April 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confi |
|
| April 10, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00 |
|
| April 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00 |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00 |
|
| March 28, 2025 |
Amended and Restated Bylaws of Abacus Global Management, Inc., dated February 27, 2025 AMENDED AND RESTATED BYLAWS OF ABACUS GLOBAL MANAGEMENT, INC. (THE “CORPORATION”) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation’s registered a |
|
| March 28, 2025 |
ABACUS GLOBAL MANAGEMENT REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS - Delivered Record Full Year Revenue and Growth While Executing on Strategic Acquisitions and Initiatives - - Fourth Quarter 2024 Total Revenue Grows 40% Year-over-Year to $33. |
|
| March 28, 2025 |
Abacus Global Management, Inc. Subsidiaries Subsidiaries State of Incorporation or Organization Longevity Market Assets, LLC Entity also does business under the name: •ABL Tech •ABL Technologies Delaware Abacus Settlements, LLC Entity also does business under the name: •Abacus Life Delaware ABL Technologies, LLC Florida Longevity Market Admin, LLC Florida Longevity Market Advisors, LLC Delaware Re |
|
| March 28, 2025 |
Form of Abacus RSU Agreement 2024 Plan ABACUS LIFE, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT (ABACUS LIFE, INC. AMENDED AND RESTATED 2024 LONG-TERM EQUITY COMPENSATION PLAN ) THIS RESTRICTED STOCK UNIT AWARD AGREEMENT, (this “Agreement”), dated as of [ ] (the “Date of Grant”), is made by and between Abacus Life, Inc., a Delaware corporation (the “Company”), and [ ] (the “Grantee” or “you” or “your”). WHEREAS, Grantee is employed by t |
|
| March 28, 2025 |
ABACUS GLOBAL MANAGEMENT, INC. INSIDER TRADING POLICY Purpose This Insider Trading Policy (“Policy”) provides guidelines with respect to transactions in the securities of Abacus Global Managemnt, Inc.(together with its subsidiaries, “Abacus”) and the handling of confidential information about Abacus and the companies with which Abacus does business. Persons Subject to the Policy All directors, off |
|
| March 28, 2025 |
Form of Abacus Option Agreement 2024 Plan ABACUS LIFE, INC. STOCK OPTION AWARD AGREEMENT (ABACUS LIFE, INC. AMENDED AND RESTATED 2024 LONG-TERM EQUITY COMPENSATION INCENTIVE PLAN) THIS STOCK OPTION AWARD AGREEMENT, (this “Agreement”), dated as of [ ] (the “Date of Grant”), is made by and between Abacus Life, Inc., a Delaware corporation (the “Company”), and [ ] (the “Grantee” or “you” or “your”). WHEREAS, Grantee is employed by the Compan |
|
| March 28, 2025 |
ABACUS LIFE, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the common stock, public warrants and 9.875% Fixed Rate Senior Notes due 2028 of Abacus Global Management, Inc. (the “Company,” “we,” “our,” or “us”), which are the only securities of the Company registered pursuant to Section 12 of the |
|
| March 28, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00 |
|
| March 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-394 |
|
| March 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00 |
|
| March 24, 2025 |
, incorporated by reference from the Company’s Form 8-K filed Abacus Global Management, Inc. Certificate of Designations Series A Convertible Preferred Stock March 17, 2025 Table of Contents Page Section 1. Definitions 1 Section 2. Rules of Construction 10 Section 3. The Convertible Preferred Stock 11 (a) Designation; Par Value 11 (b) Number of Authorized Shares 11 (c) Form, Dating and Denominations 11 (d) Method of Payment; Delay When Payment Date is Not a |
|
| March 5, 2025 |
exhibit31-amendedcertifi Delaware The First State Page 1 7983570 8100 Authentication: 203072727 SR# 20250810203 Date: 03-04-25 You may verify this certificate online at corp. |
|
| March 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) |
|
| February 4, 2025 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-284325 PROSPECTUS 9,213,735 Shares of Common Stock $72,727,075 Aggregate Principal Amount of 9.875% Fixed Rate Senior Notes due 2028 This prospectus relates to the resale or other disposition from time to time of up to (i) 9,213,735 shares (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”) and (ii) $72,727,075 aggr |
|
| January 31, 2025 |
Abacus Life, Inc. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 January 31, 2025 Abacus Life, Inc. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 January 31, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Aisha Adegbuyi Re: Abacus Life, Inc. Registration Statement on Form S-3 File No. 333-284325 Ladies and Gentlemen: In accordance with Rule 461 of Regulation C o |
|
| January 16, 2025 |
Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) £ U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E |
|
| January 16, 2025 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-3 (Form Type) ABACUS LIFE, INC. |
|
| January 16, 2025 |
As filed with the Securities and Exchange Commission on January 16, 2025 As filed with the Securities and Exchange Commission on January 16, 2025 Registration No. |
|
| December 16, 2024 |
ABACUS LIFE, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT (ABACUS LIFE, INC. AMENDED AND RESTATED 2024 LONG-TERM EQUITY COMPENSATION PLAN ) THIS RESTRICTED STOCK UNIT AWARD AGREEMENT, (this “Agreement”), dated as of [ ] (the “Date of Grant”), is made by and between Abacus Life, Inc., a Delaware corporation (the “Company”), and [ ] (the “Grantee” or “you” or “your”). WHEREAS, Grantee is employed by t |
|
| December 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C |
|
| December 10, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Abacus Life, Inc. (Name of Issuer) Common Stock - $0.0001 par value per share (Title of Class of Securities) 274681105 (CUSIP Number) Pillo Portsmouth Holding Company, LLC 1658 N. Milwaukee Avenue, Suite 334 Chicago, Illinois 60647 Telephone: c/o +325-268-4-53-59 Copy |
|
| December 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C |
|
| December 10, 2024 |
Joint Filing Agreement, dated as of December 2, 2024 Exhibit 1 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with respect to securities of Abacus Life, Inc. |
|
| December 10, 2024 |
Abacus Life Closes $150 Million Debt Financing Facility to Support Continued Growth Abacus Life Closes $150 Million Debt Financing Facility to Support Continued Growth ORLANDO, Fla. |
|
| December 10, 2024 |
Execution Version SECURITY AGREEMENT dated December 10, 2024 among The Grantors referred to herein, as Grantors and GLAS USA LLC, as Collateral Agent Schedules: Schedule I - Location, Chief Executive Office, Jurisdiction of Organization, Organizational Identification Number, Tax Identification Number, Prior Names, etc. |
|
| December 10, 2024 |
Execution Version GUARANTY Dated as of December 10, 2024 among ABACUS LIFE, INC. THE OTHER GUARANTORS NAMED HEREIN and EACH ADDITIONAL GUARANTOR THAT BECOMES A PARTY HERETO, as Guarantors, and GLAS USA LLC, as Administrative Agent #4919-0286-4389v3 TABLE OF CONTENTS Section Page The table of contents is empty. Heading styles must be applied in the document and be selected in the table of contents |
|
| December 10, 2024 |
Execution Version CREDIT AGREEMENT Dated as of December 10, 2024 among Abacus Life, Inc. |
|
| December 2, 2024 |
Abacus Life Completes Acquisition of FCF Advisors Abacus Life Completes Acquisition of FCF Advisors ORLANDO, Fla., December 2, 2024 (GLOBE NEWSWIRE) - Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announced it has completed the acquisition of FCF Advisors (“FCF”), a N |
|
| December 2, 2024 |
NOTES REGISTRATION RIGHTS AGREEMENT THIS NOTES REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December 2, 2024, is made and entered into by and among Abacus Life, Inc. |
|
| December 2, 2024 |
SECOND SUPPLEMENTAL INDENTURE between ABACUS LIFE, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee Dated as of December 2, 2024 THIS SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”), dated as of December 2, 2024, is between Abacus Life, Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). |
|
| December 2, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Co |
|
| December 2, 2024 |
SHARE LOCK-UP AND STANDSTILL AGREEMENT This Share Lock-Up and Standstill Agreement (as amended, restated, supplemented or otherwise modified in accordance with Section 8. |
|
| December 2, 2024 |
Abacus Life Completes Acquisition of Carlisle Management Company S.C.A. Abacus Life Completes Acquisition of Carlisle Management Company S.C.A. ORLANDO, Fla., December 2, 2024 (GLOBE NEWSWIRE) - Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announced it has completed the acquisition of Car |
|
| December 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Co |
|
| December 2, 2024 |
EQUITY REGISTRATION RIGHTS AGREEMENT THIS EQUITY REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December 2, 2024, is made and entered into by and among Abacus Life, Inc. |
|
| November 25, 2024 |
Exhibit 1.1 12,500,000 Shares ABACUS LIFE, INC. Common Stock UNDERWRITING AGREEMENT November 21, 2024 Piper Sandler & Co. TD Securities (USA) LLC KKR Capital Markets LLC B. Riley Securities, Inc. SG Americas Securities, LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 c/o TD Securit |
|
| November 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 25, 2024 |
Exhibit 99.1 Abacus Life Announces Pricing of Public Offering of Common Stock November 21, 2024 ORLANDO, November 21, 2024-(GLOBE NEWS WIRE) — Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common stock, |
|
| November 25, 2024 |
Prospectus Supplement to Prospectus dated October 21, 2024 10,000,000 Shares of Common Stock Filed Pursuant to Rule 424(b)(2) Registration No. 333-282747 Prospectus Supplement to Prospectus dated October 21, 2024 10,000,000 Shares of Common Stock Abacus Life, Inc. (“Abacus,” “we,” “our,” “us” and the “Company) is offering 10,000,000 shares of the Company’s common stock, par value $0.0001 (the “Common Stock”). You should read this prospectus supplement and any other prospectus supplement o |
|
| November 25, 2024 |
Prospectus Supplement to Prospectus dated October 21, 2024 2,500,000 Shares of Common Stock Filed Pursuant to Rule 424(b)(7) Registration No. 333-273411 Prospectus Supplement to Prospectus dated October 21, 2024 2,500,000 Shares of Common Stock The selling securityholders identified in this prospectus supplement (the “Selling Securityholders”) are offering 2,500,000 shares of our common stock, par value $0.0001 per share (the “Common Stock”). You should read this prospectus supplement an |
|
| November 25, 2024 |
Exhibit 99.2 Abacus Life Announces Closing of Public Offering of 12,500,000 Shares of Common Stock November 25, 2024 ORLANDO, Fla., November 25, 2024 (GLOBE NEWSWIRE) – Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering |
|
| November 22, 2024 |
Exhibit 99.1 Abacus Life Announces Proposed Public Offering of Common Stock November 21, 2024 ORLANDO, Fla., November 21, 2024 (GLOBE NEWSWIRE) - Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in leveraging longevity and actuarial technology to offer uncorrelated investment opportunities, today announced the commencement of an under |
|
| November 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 21, 2024 |
The information in this preliminary prospectus supplement is not complete and may be changed. |
|
| November 21, 2024 |
The information in this preliminary prospectus supplement is not complete and may be changed. |
|
| November 13, 2024 |
ABACUS LIFE, INC. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 ABACUS LIFE, INC. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 VIA EDGAR November 13, 2024 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Madeleine Joy Mateo Christian Windsor Re: Abacus Life, Inc. Registration Statement on Form S-3 Filed October 21, 2024 File No. 333-282747 Ladies and Gentlemen: Pursuant |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| November 7, 2024 |
Abacus Life, Inc. Subsidiaries Subsidiaries State of Incorporation or Organization Longevity Market Assets, LLC Entity also does business under the name: •ABL Tech •ABL Technologies Delaware Abacus Settlements, LLC Entity also does business under the name: •Abacus Life Delaware ABL Technologies, LLC Florida Longevity Market Admin, LLC Florida Longevity Market Advisors, LLC Delaware Regional Invest |
|
| November 7, 2024 |
November 7, 2024 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N. |
|
| November 7, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Co |
|
| November 7, 2024 |
ABACUS LIFE REPORTS THIRD QUARTER 2024 RESULTS - Delivered Continued Revenue and Profitability Growth While Executing on Strategic Initiatives - - Third Quarter 2024 Total Revenue Grows 33% Year-over-Year to $28. |
|
| November 7, 2024 |
November 7, 2024 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N. |
|
| November 4, 2024 |
November 4, 2024 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N. |
|
| November 4, 2024 |
November 4, 2024 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N. |
|
| October 22, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Co |
|
| October 22, 2024 |
ABACUS LIFE PROVIDES PRELIMINARY THIRD QUARTER 2024 RESULTS - Expects Total Revenue Between $26. |
|
| October 21, 2024 |
As filed with the Securities and Exchange Commission on October 21, 2024 As filed with the Securities and Exchange Commission on October 21, 2024 Registration No. |
|
| October 21, 2024 |
Exhibit 107 Calculation of Filing Fee Table Registration Statement on Form S-3 (Form Type) Abacus Life, Inc. |
|
| October 21, 2024 |
EX-FILING FEES 2 exhibit107-posam.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) Abacus Life, Inc. (Exact Name of Registrant as Specified in its Charter) Newly Registered and Carry Forward Shares Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price |
|
| October 21, 2024 |
As filed with the Securities and Exchange Commission on October 21, 2024 As filed with the Securities and Exchange Commission on October 21, 2024 Registration No. |
|
| August 12, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Com |
|
| August 12, 2024 |
ABACUS LIFE REPORTS SECOND QUARTER 2024 RESULTS - Second Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $29. |
|
| August 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001 |
|
| August 7, 2024 |
Abacus Life Announces Agreement to Acquire FCF Advisors Acquisition accelerates expansion of ABL Wealth with a diverse suite of products Deal will add up to $600 million in AUM to Abacus ORLANDO, Fla. |
|
| August 7, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Comm |
|
| August 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Comm |
|
| July 18, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Commi |
|
| July 18, 2024 |
Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA Acquisition accelerates Abacus' expansion as a global alternative asset manager and origination company Deal will add up to $2 billion in AUM to Abacus ORLANDO, Fla. |
|
| July 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Commi |
|
| July 18, 2024 |
SHARE PURCHASE AGREEMENT BY AND AMONG ABACUS LIFE, INC., CARLISLE MANAGEMENT COMPANY S.C.A., CARLISLE INVESTMENT GROUP S. À R.L., THE SELLERS PARTY HERETO, JOSE ESTEBAN CASARES GARCIA, (solely with respect to Section 4.8, Section 6.11, Section 6.12, Section 6.18, Section 6.20, Section 9.4(c), and Section 9.4(d)), MANORHAVEN HOLDINGS, LLC, (solely with respect to Section 6.11 and Section 6.12) PACI |
|
| July 18, 2024 |
ABACUS LIFE PROVIDES PRELIMINARY SECOND QUARTER 2024 RESULTS - Expects Total Revenue Between $28. |
|
| June 28, 2024 |
Calculation of Filing Fee Table Form S-8 (Form Type) Abacus Life, Inc. (Exact Name of Registrant as Specified in its Charter) Newly Registered and Carry Forward Shares Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fee |
|
| June 28, 2024 |
As filed with the Securities and Exchange Commission on June 28, 2024. As filed with the Securities and Exchange Commission on June 28, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. E |
|
| June 24, 2024 |
Abacus Life Announces Pricing of Public Offering of Common Stock Exhibit 99.1 Abacus Life Announces Pricing of Public Offering of Common Stock June 20, 2024 ORLANDO, June 20, 2024-(GLOBE NEWS WIRE) — Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the pricing of its oversubscribed underwritten public offering of 10,000,000 shares of its common |
|
| June 24, 2024 |
Abacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock Exhibit 99.2 Abacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock June 24, 2024 ORLANDO, Fla., June 24, 2024 (GLOBE NEWSWIRE) – Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering of 11,50 |
|
| June 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 24, 2024 |
Exhibit 1.1 10,000,000 Shares ABACUS LIFE, INC. Common Stock UNDERWRITING AGREEMENT June 20, 2024 Piper Sandler & Co. TD Securities (USA) LLC B. Riley Securities, Inc. KKR Capital Markets LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 c/o TD Securities (USA) LLC 1 Vanderbilt Avenu |
|
| June 21, 2024 |
10,000,000 Shares Common Stock Filed Pursuant to Rule 424(b)(1) Registration No. 333-279347 Prospectus 10,000,000 Shares Common Stock This is an offering of common stock by Abacus Life, Inc. (the “Company”). We are offering 10,000,000 shares of the Company’s common stock. You should read this prospectus and any prospectus supplement or amendment carefully before you invest in our securities. Our common stock is listed on The Na |
|
| June 17, 2024 |
ABACUS LIFE, INC. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 ABACUS LIFE, INC. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 VIA EDGAR June 17, 2024 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Aisha Adegbuyi Christian Windsor Re: Abacus Life, Inc. Registration Statement on Form S-1 Filed May 10, 2024 File No. 333-279347 Ladies and Gentlemen: Pursuant to Rule 461 |
|
| June 17, 2024 |
VIA EDGAR Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 TD Securities (USA) LLC 1 Vanderbilt Avenue New York, New York 10017 B. Riley Securities, Inc. 1300 17th Street North, Suite 1300 Arlington, Virginia 22209 KKR Capital Markets LLC 30 Hudson Yards, 75th Floor New York, New York 10001 June 17, 2024 Securities and Exchange Commission Division of Corporation |
|
| June 14, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Commi |
|
| June 13, 2024 |
As filed with the Securities and Exchange Commission on June 13, 2024. As filed with the Securities and Exchange Commission on June 13, 2024. Registration No. 333-279347 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of Incorporation o |
|
| June 13, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 13, 2024 |
Abacus Life Announces Proposed Public Offering of Common Stock Exhibit 99.1 Abacus Life Announces Proposed Public Offering of Common Stock June 13, 2024 ORLANDO, Fla., June 13, 2024 (GLOBE NEWSWIRE) - Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock |
|
| June 13, 2024 |
Exhibit 107 Calculation of Filing Fee Table Registration Statement on Form S-1 (Form Type) Abacus Life, Inc. |
|
| June 13, 2024 |
Form of Underwriting Agreement. Exhibit 1.1 [ ò ] Shares ABACUS LIFE, INC. Common Stock UNDERWRITING AGREEMENT [ ò ], 2024 Piper Sandler & Co. TD Securities (USA) LLC B. Riley Securities, Inc. KKR Capital Markets LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 c/o TD Securities (USA) LLC 1 Vanderbilt Avenue New Y |
|
| June 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-3 |
|
| May 31, 2024 |
Form of Underwriting Agreement. Exhibit 1.1 [l] Shares ABACUS LIFE, INC. Common Stock UNDERWRITING AGREEMENT [l], 2024 Piper Sandler & Co. TD Securities (USA) LLC KKR Capital Markets LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 c/o TD Securities (USA) LLC 1 Vanderbilt Avenue New York, New York 10017 c/o KKR Ca |
|
| May 31, 2024 |
As filed with the Securities and Exchange Commission on May 30, 2024. As filed with the Securities and Exchange Commission on May 30, 2024. Registration No. 333-279347 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of Incorporation or |
|
| May 30, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission |
|
| May 30, 2024 |
811 Main Street, Suite 3700 Houston, TX 77002 Tel: +1.713.546.5400 Fax: +1.713.546.5401 www.lw.com FIRM / AFFILIATE OFFICES Austin Milan Beijing Munich Boston New York Brussels Orange County Century City Paris Chicago Riyadh Dubai San Diego Düsseldorf San Francisco Frankfurt Seoul Hamburg Silicon Valley Hong Kong Singapore Houston Tel Aviv London Tokyo Los Angeles Washington, D.C. Madrid May 30, 2 |
|
| May 13, 2024 |
1 ABACUS LIFE REPORTS FIRST QUARTER 2024 RESULTS - First Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $21. |
|
| May 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00 |
|
| May 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Commis |
|
| May 10, 2024 |
As filed with the Securities and Exchange Commission on May 10, 2024. As filed with the Securities and Exchange Commission on May 10, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of Incorporation or Organization) (Primary S |
|
| May 10, 2024 |
Exhibit 107 Calculation of Filing Fee Table Registration Statement on Form S-1 (Form Type) Abacus Life, Inc. |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confi |
|
| April 26, 2024 |
As confidentially submitted with the Securities and Exchange Commission on April 26, 2024. As confidentially submitted with the Securities and Exchange Commission on April 26, 2024. |
|
| March 21, 2024 |
Description of registrant’s securities 2023. ABACUS LIFE, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the common stock of Abacus Life, Inc. (the “Company,” “we,” “our,” or “us”), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The followi |
|
| March 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-394 |
|
| March 21, 2024 |
ABACUS LIFE, INC CLAWBACK POLICY Policy Statement It is the policy of Abacus Life, Inc. |
|
| March 21, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Comm |
|
| March 21, 2024 |
ABACUS LIFE REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS - Fourth Quarter 2023 Total Revenue Grew 25% Year-over-Year to $23. |
|
| February 15, 2024 |
Execution Version ABACUS LIFE, INC. $25,000,000 9.875% Fixed Rate Senior Notes due 2028 UNDERWRITING AGREEMENT February 9, 2024 Piper Sandler & Co., As representative of the several Underwriters c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 Ladies and Gentlemen: Abacus Life, Inc., a Delaware corporation (the “Company”), confirms its agreements with Piper S |
|
| February 15, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Co |
|
| February 15, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C |
|
| February 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C |
|
| February 13, 2024 |
US00258Y1047 / ABACUS LIFE INC / SZOP MULTISTRAT LP Passive Investment SC 13G/A 1 formsc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Abacus Life, Inc. (f/k/a East Resources Acquisition Co) (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 00258Y104 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Stat |
|
| February 13, 2024 |
9.875% Fixed Rate Senior Notes due 2028 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-276795 PROSPECTUS $25,000,000 9.875% Fixed Rate Senior Notes due 2028 Abacus Life, Inc., a Delaware corporation (“Abacus” or the “Company”), is offering an additional $25,000,000 aggregate principal amount (the “notes”) of its 9.875% Fixed Rate Senior Notes due 2028 that are listed on the Nasdaq Global Market® (“NASDAQ”) under |
|
| February 12, 2024 |
US00258Y1047 / ABACUS LIFE INC / Alberta Investment Management Corp - SC 13G/A Passive Investment SC 13G/A 1 d744854dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) ABACUS LIFE, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 00258Y104 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appro |
|
| February 9, 2024 |
As filed with the Securities and Exchange Commission on February 9 , 2024. Table of Contents As filed with the Securities and Exchange Commission on February 9 , 2024. |
|
| February 9, 2024 |
Form of Underwriting Agreement. Exhibit 1.1 ABACUS LIFE, INC. $15,000,000 9.875% Fixed Rate Senior Notes due 2028 UNDERWRITING AGREEMENT February 9, 2024 Piper Sandler & Co., As representative of the several Underwriters c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 Ladies and Gentlemen: Abacus Life, Inc., a Delaware corporation (the “Company”), confirms its agreements with Piper Sandler |
|
| February 7, 2024 |
February 7, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street NE Washington, D. |
|
| February 7, 2024 |
VIA EDGAR Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 February 7, 2024 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: John Stickel Re: Abacus Life, Inc. Registration Statement on Form S-1 File No. 333-276795 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933 |
|
| January 31, 2024 |
As filed with the Securities and Exchange Commission on January 31, 2024. Table of Contents As filed with the Securities and Exchange Commission on January 31, 2024. |
|
| January 31, 2024 |
Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) Abacus Life, Inc. |
|
| January 9, 2024 |
a991-abacusliferepurchas Abacus Life Repurchases $1.9 Million of Stock in First 30 Days of Program January 9, 2024 1:00 PM EST ORLANDO, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) - Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, provided an update to i |
|
| January 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Com |
|
| December 29, 2023 |
a101-amendment1xtoxspon AMENDMENT NO. 1 to SPONSOR SUPPORT AGREEMENT This Amendment No. 1 to the Sponsor Support Agreement (this “Amendment”), is entered into as of December 20, 2023, by and among Abacus Life, Inc., a Delaware corporation formerly known as East Resources Acquisition Company (“Abacus Life”), Longevity Market Assets, LLC (“LMA”), Abacus Settlements, LLC (“Abacus Settlements”), and E |
|
| December 29, 2023 |
a103-abacusxxletterxagr 135715511v.2 ABACUS LIFE, INC. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 December 20, 2023 Lifebridge Holdings, LLC 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 East Sponsor, LLC 7777 NW Beacon Square Boulevard Boca Raton, Florida 33487 Re: Private Warrant Standstill Ladies and Gentlemen: Reference is made to the warrants to purchase shares of com |
|
| December 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C |
|
| December 29, 2023 |
a102-amendment1xtoxcomp AMENDMENT NO. 1 to COMPANY SUPPORT AGREEMENT This Amendment No. 1 to the Company Support Agreement (this “Amendment”), is entered into as of December 20, 2023, by and among Abacus Life, Inc., a Delaware corporation formerly known as East Resources Acquisition Company (“Abacus Life”), Longevity Market Assets, LLC (“LMA”), Abacus Settlements, LLC (“Abacus Settlements”), each |
|
| December 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C |
|
| December 12, 2023 |
Abacus Life Announces $15 Million Stock Repurchase Program Abacus Life Announces $15 Million Stock Repurchase Program Orlando, Fla. – December 11, 2023 – Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, announced today that its Board of Directors has authorized a new stock repurchase program of up to $15 |
|
| November 20, 2023 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 85-1210472 (State of Incorporation or Organization) (I.R.S. Employer Identification No.) 2101 Park Center Drive, Suite 170 O |
|
| November 20, 2023 |
3Q 2023 IMPORTANT NOTE TO INVESTORS: On or about November 14, 2023 a document titled “Abacus Life Q3 Board Presentation November 9, 2023” (the “Disclaimed Document”) entered the public domain. |
|
| November 20, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C |
|
| November 13, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C |
|
| November 13, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation or organ |
|
| November 13, 2023 |
ABACUS LIFE REPORTS THIRD QUARTER 2023 RESULTS - Total Revenue Grew 20% Year-over-Year to $21. |
|
| November 13, 2023 |
Base Indenture, incorporated by reference from the Company’s Form 8-K filed November 13, 2023. Exhibit 4.1 ABACUS LIFE, INC., ISSUER AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, TRUSTEE SENIOR DEBT SECURITIES INDENTURE Dated as of November 10, 2023 TABLE OF CONTENTS Page ARTICLE I Definitions and Other Provisions of General Application 1 Section 1.1 Definitions 1 Section 1.2 Compliance Certificates and Opinions 6 Section 1.3 Form of Documents Delivered to Trustee 7 Section 1.4 Acts of |
|
| November 13, 2023 |
Exhibit 4.2 FIRST SUPPLEMENTAL INDENTURE between ABACUS LIFE, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee Dated as of November 10, 2023 THIS FIRST SUPPLEMENTAL INDENTURE (this “First Supplemental Indenture”), dated as of November 10, 2023, is between Abacus Life, Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| November 6, 2023 |
Exhibit 1.1 ABACUS LIFE, INC. $31,000,000 9.875% Fixed Rate Senior Notes due 2028 UNDERWRITING AGREEMENT November 2, 2023 Piper Sandler & Co., As representative of the several Underwriters c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 Ladies and Gentlemen: Abacus Life, Inc., a Delaware corporation (the “Company”), confirms its agreements with Piper Sandler |
|
| November 6, 2023 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation or organi |
|
| November 6, 2023 |
9.875% Fixed Rate Senior Notes due 2028 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-274553 PROSPECTUS $31,000,000 9.875% Fixed Rate Senior Notes due 2028 Abacus Life, Inc., a Delaware corporation (“Abacus” or the “Company”), is offering $31,000,000 aggregate principal amount of Fixed Rate Senior Notes (the “notes”). The notes will bear interest at the rate of 9.875% per annum, payable quarterly in arrears on |
|
| November 1, 2023 |
Table of Contents As filed with the Securities and Exchange Commission on November 1, 2023. |
|
| October 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Co |
|
| October 31, 2023 |
October 31, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street NE Washington, D. |
|
| October 31, 2023 |
VIA EDGAR Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 October 31, 2023 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Aisha Adegbuyi and Christian Windsor Re: Abacus Life, Inc. Registration Statement on Form S-1 File No. 333-274553 Ladies and Gentlemen: In accordance with Rule 461 under the |
|
| October 30, 2023 |
200 Vesey Street, 20th Floor, New York, NY 10281 Telephone: 212-912-2736 Fax: 888-325-9109 www. |
|
| October 30, 2023 |
Table of Contents As filed with the Securities and Exchange Commission on October 30 , 2023. |
|
| October 26, 2023 |
As filed with the Securities and Exchange Commission on October 26, 2023. S-8 As filed with the Securities and Exchange Commission on October 26, 2023. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of (Primary Standard Industrial ( |
|
| October 26, 2023 |
EX-FILING FEES Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Abacus Life, Inc. |
|
| October 20, 2023 |
EX-99.1 Exhibit 99.1 TRANSFER AGREEMENT This Transfer Agreement made this 13th day of October, 2023, between Jay Jackson, Todd Sean McNealy, Kevin Scott Kirby, and Matthew A. Ganovsky (each a “Transferor” and together the Transferors) and East Sponsor, LLC, a limited liability company existing under the laws of the State of Delaware (“Transferee” and together with the Transferors, each a “Party” a |
|
| October 20, 2023 |
EX-99.1 2 d541835dex991.htm EX-99.1 Exhibit 99.1 TRANSFER AGREEMENT This Transfer Agreement made this 13th day of October, 2023, between Jay Jackson, Todd Sean McNealy, Kevin Scott Kirby, and Matthew A. Ganovsky (each a “Transferor” and together the Transferors) and East Sponsor, LLC, a limited liability company existing under the laws of the State of Delaware (“Transferee” and together with the T |
|
| October 20, 2023 |
ERES / Abacus Life Inc - Class A / Ganovsky Matthew - SC 13D/A Activist Investment SC 13D/A 1 d541835dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Abacus Life, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00258Y104 (CUSIP Number) Matthew Ganovsky c/o Abacus Life, Inc. 2101 Park Center Drive, Suite 170 Orlando, F |
|
| October 20, 2023 |
ERES / Abacus Life Inc - Class A / Kirby Kevin Scott - SC 13D/A Activist Investment SC 13D/A 1 d549493dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Abacus Life, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00258Y104 (CUSIP Number) Kevin Scott Kirby c/o Abacus Life, Inc. 2101 Park Center Drive, Suite 170 Orlando, |
|
| October 20, 2023 |
ERES / Abacus Life Inc - Class A / McNealy Sean - SC 13D/A Activist Investment SC 13D/A 1 d541350dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Abacus Life, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00258Y104 (CUSIP Number) Sean McNealy c/o Abacus Life, Inc. 2101 Park Center Drive, Suite 170 Orlando, Flori |
|
| October 20, 2023 |
EX-99.1 2 d541350dex991.htm EX-99.1 Exhibit 99.1 TRANSFER AGREEMENT This Transfer Agreement made this 13th day of October, 2023, between Jay Jackson, Todd Sean McNealy, Kevin Scott Kirby, and Matthew A. Ganovsky (each a “Transferor” and together the Transferors) and East Sponsor, LLC, a limited liability company existing under the laws of the State of Delaware (“Transferee” and together with the T |
|
| October 20, 2023 |
ERES / Abacus Life Inc - Class A / Jackson Jay J - SC 13D/A Activist Investment SC 13D/A 1 d452450dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Abacus Life, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00258Y104 (CUSIP Number) Jay Jackson c/o Abacus Life, Inc. 2101 Park Center Drive, Suite 170 Orlando, Florid |
|
| October 20, 2023 |
EX-99.1 2 d549493dex991.htm EX-99.1 Exhibit 99.1 TRANSFER AGREEMENT This Transfer Agreement made this 13th day of October, 2023, between Jay Jackson, Todd Sean McNealy, Kevin Scott Kirby, and Matthew A. Ganovsky (each a “Transferor” and together the Transferors) and East Sponsor, LLC, a limited liability company existing under the laws of the State of Delaware (“Transferee” and together with the T |
|
| October 17, 2023 |
EX-99.9 2 d536661dex999.htm EX-99.9 Exhibit 9 TRANSFER AGREEMENT This Transfer Agreement made this 13th day of October, 2023, between Jay Jackson, Todd Sean McNealy, Kevin Scott Kirby, and Matthew A. Ganovsky (each a “Transferor” and together the Transferors) and East Sponsor, LLC, a limited liability company existing under the laws of the State of Delaware (“Transferee” and together with the Tran |
|
| October 17, 2023 |
ERES / Abacus Life Inc - Class A / Pegula Terrence M. - SC 13D/A Activist Investment SC 13D/A 1 d536661dsc13da.htm SC 13D/A United States Securities and Exchange Commission Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240.13d-1(a) and Amendments Thereto Filed Pursuant to § 240.13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 1)* Abacus Life, Inc. (Name of Issuer) Common Stock (Title of Class of Sec |
|
| October 11, 2023 |
October 11, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street NE Washington, D. |
|
| September 29, 2023 |
Form of Underwriting Agreement. Exhibit 1.1 ABACUS LIFE, INC. $[●] [●]% Fixed Rate Senior Notes due 2028 UNDERWRITING AGREEMENT [•], 2023 Piper Sandler & Co., As representative of the several Underwriters c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 Ladies and Gentlemen: Abacus Life, Inc., a Delaware corporation (the “Company”), confirms its agreements with Piper Sandler & Co. (“Piper S |
|
| September 29, 2023 |
Exhibit 3.3 ABACUS LIFE, INC., ISSUER AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, TRUSTEE SENIOR DEBT SECURITIES INDENTURE Dated as of [ ] [ ], 2023 TABLE OF CONTENTS Page ARTICLE I Definitions and Other Provisions of General Application 1 Section 1.1 Definitions 1 Section 1.2 Compliance Certificates and Opinions 6 Section 1.3 Form of Documents Delivered to Trustee 7 Section 1.4 Acts of |
|
| September 29, 2023 |
111 South Wacker Drive Suite 4100 Chicago, IL 60606 Telephone: 312-443-0700 Fax: 312-443-0336 www. |
|
| September 29, 2023 |
Table of Contents As filed with the Securities and Exchange Commission on September 29, 2023. |
|
| September 29, 2023 |
Form of Fixed Rate Senior Notes (included in Exhibit 3.4) Exhibit 3.4 FIRST SUPPLEMENTAL INDENTURE between ABACUS LIFE, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee Dated as of [ ] [ ], 2023 THIS FIRST SUPPLEMENTAL INDENTURE (this “First Supplemental Indenture”), dated as of [ ] [ ], 2023, is between Abacus Life, Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “T |
|
| September 29, 2023 |
111 South Wacker Drive Suite 4100 Chicago, IL 60606 Telephone: 312-443-0700 Fax: 312-443-0336 www. |
|
| September 29, 2023 |
Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E |
|
| September 29, 2023 |
Table of Contents As filed with the Securities and Exchange Commission on September 29, 2023. |
|
| September 18, 2023 |
As filed with the Securities and Exchange Commission on September 15, 2023. Table of Contents As filed with the Securities and Exchange Commission on September 15, 2023. |
|
| September 18, 2023 |
Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) Abacus Life, Inc. |
|
| September 15, 2023 |
Table of Contents As filed with the Securities and Exchange Commission on September 1 5 , 2023. |
|
| September 15, 2023 |
EX-FILING FEES Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) Abacus Life, Inc. |
|
| September 15, 2023 |
111 South Wacker Drive Suite 4100 Chicago, IL 60606 Telephone: 312-443-0700 Fax: 312-443-0336 www. |
|
| August 25, 2023 |
ABACUS LIFE PRESENTS HISTORICAL QUARTERLY AND FULL YEAR 2022 FINANCIALS Exhibit 99.1 ABACUS LIFE PRESENTS HISTORICAL QUARTERLY AND FULL YEAR 2022 FINANCIALS ORLANDO, Fla. – August 25, 2023 – Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today is releasing its unaudited historical quarterly and full year 2022 financ |
|
| August 25, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation or organiz |
|
| August 14, 2023 |
Exhibit 99.1 ABACUS LIFE REPORTS SECOND QUARTER 2023 RESULTS - Revenue Grew 30% Year-over-Year to $18.3 Million - - Increased Originations Capital Deployment by 88% Year-over-Year to $59.7 Million - - Net Income Increased 40% Year-over-Year to $6.4 Million - - Adjusted EBITDA Grew 33% Year-over-Year to $8.8 Million - ORLANDO, Fla. – August 14, 2023 – Abacus Life, Inc. (“Abacus” or the “Company”) ( |
|
| August 14, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation or organiz |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001 |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) * East Resources Acquisition Company (Name of Issuer) Common (Title of Class of Securities) 274681105 (CUSIP Number) July 31, 2023 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which th |
|
| July 25, 2023 |
Exhibit 10.10 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (“Agreement”) is entered into by and between ABACUS LIFE, INC., a Delaware corporation (the “Employer”), and [NAME OF EXECUTIVE], an individual (the “Executive”). WHEREAS, the Executive will be employed as [ ]; and WHEREAS, the Employer and the Executive desire to enter into this Agreement to set out the terms and conditions for the empl |
|
| July 25, 2023 |
As filed with the Securities and Exchange Commission on July 25, 2023. S-1 Table of Contents As filed with the Securities and Exchange Commission on July 25, 2023. |
|
| July 25, 2023 |
EX-FILING FEES Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) Abacus Life, Inc. |
|
| July 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation or organizat |
|
| July 20, 2023 |
Letter from Marcum LLP to the Securities and Exchange Commission. EX-16.1 Exhibit 16.1 July 20, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Abacus Life, Inc. (formerly known as East Resources Acquisition Company) under Item 4.01 of its Form 8-K dated July 17, 2023. We agree with the statements concerning our Firm under Item 4.01 in such Form 8-K. We are not in a position to ag |
|
| July 10, 2023 |
ERES / Abacus Life Inc - Class A / Jackson Jay J - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Abacus Life, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 1814287 (CUSIP Number) Jay Jackson c/o Abacus Life, Inc. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 (Name, Address and Telephone Number of Perso |
|
| July 10, 2023 |
SNC / State National Companies, Inc. / McNealy Sean - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Abacus Life, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 1814287 (CUSIP Number) Sean McNealy c/o Abacus Life, Inc. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 (Name, Address and Telephone Number of Pers |
|
| July 10, 2023 |
ERES / Abacus Life Inc - Class A / Ganovsky Matthew - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Abacus Life, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 1814287 (CUSIP Number) Matthew Ganovsky c/o Abacus Life, Inc. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 (Name, Address and Telephone Number of |
|
| July 10, 2023 |
EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13D. Each of them is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning |
|
| July 10, 2023 |
ERES / Abacus Life Inc - Class A / Kirby Kevin Scott - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Abacus Life, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 1814287 (CUSIP Number) Kevin Scott Kirby c/o Abacus Life, Inc. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 (Name, Address and Telephone Number of |
|
| July 10, 2023 |
ERES / Abacus Life Inc - Class A / Pegula Terrence M. - SC 13D Activist Investment SC 13D United States Securities and Exchange Commission Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240.13d-1(a) and Amendments Thereto Filed Pursuant to § 240.13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. )* Abacus Life, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00258Y 104 (CUSIP Number |
|
| July 6, 2023 |
EX-14.1 Exhibit 14.1 ABACUS LIFE, INC. CODE OF BUSINESS CONDUCT AND ETHICS ADOPTED JUNE 30, 2023 Introduction In accordance with the requirements of the Securities and Exchange Commission (the “SEC”) and the National Association of Securities Dealers Automated Quotations Stock Market (“NASDAQ”) Listing Standards, the Board of Directors (the “Board”) of Abacus Life, Inc. (the “Company”) has adopted |
|
| July 6, 2023 |
EX-21.1 Exhibit 21.1 Subsidiaries • Longevity Market Assets, LLC • Abacus Settlements, LLC • LMX Series, LLC • LMA Series, LLC • Longevity Market Admin, LLC • Longevity Market Advisors, LLC • Longevity Market Technologies, LLC • LMATT Series 2024, Inc. • LMATT Growth Series 2.204, Inc. • LMATT Growth and Income Series 1.2026, Inc. • Regional Investment Services, Inc. • Longevity Wealth Advisors, L |
|
| July 6, 2023 |
EX-99.2 Exhibit 99.2 Abacus Settlements, LLC d/b/a Abacus Life Financial Statements as of and for the Years Ended December 31, 2022, and 2021, and Report of Independent Registered Public Accounting Firm 1 ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE TABLE OF CONTENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 3 AUDITED FINANCIAL STATEMENTS AS OF AND FOR THE YEARS ENDED DECEMBER 31, |
|
| July 6, 2023 |
EX-3.1 Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF EAST RESOURCES ACQUISITION COMPANY June 30, 2023 East Resources Acquisition Company, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “East Resources Acquisition Company”. The original certificate of incorp |
|
| July 6, 2023 |
EX-10.9 Exhibit 10.9 ABACUS LIFE, INC. STOCK OPTION AWARD AGREEMENT (2023 LONG-TERM EQUITY COMPENSATION INCENTIVE PLAN) THIS STOCK OPTION AWARD AGREEMENT, (this “Agreement”), dated as of [ ] (the “Date of Grant”), is made by and between Abacus Life, Inc., a Delaware corporation (the “Company”), and [ ] (the “Grantee” or “you” or “your”). WHEREAS, Grantee is employed by the Company or an Affiliate; |
|
| July 6, 2023 |
EX-10.1 Exhibit 10.1 EAST RESOURCES ACQUISITION COMPANY WARRANT FORFEITURE AGREEMENT This Warrant Forfeiture Agreement (the “Agreement”) is effective as of June 30, 2023, by and between East Resources Acquisition Company, a Delaware corporation (the “Company”), and East Sponsor, LLC, a Delaware limited liability company (“Warrant Holder”). RECITALS WHEREAS, Warrant Holder is the record owner of 8, |
|
| July 6, 2023 |
EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ABACUS LIFE, INC. (THE “CORPORATION”) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation’s regist |
|
| July 6, 2023 |
Exhibit 10.6 FORM OF INDEMNIFICATION AND ADVANCEMENT AGREEMENT This INDEMNIFICATION AND ADVANCEMENT AGREEMENT (this “Agreement”) is made as of [•], 2023, by and between Abacus Life, Inc., a Delaware corporation (the “Company”), and [•] (“Indemnitee”), [ a member of the Board of Directors of the Company ] / [ an officer of the Company ]. This Agreement supersedes and replaces any and all previous a |
|
| July 6, 2023 |
EX-10.2 Exhibit 10.2 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 30, 2023, is made and entered into by and among Abacus Life, Inc., a Delaware corporation, f/k/a East Resources Acquisition Company (the “Company”), East Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), and the under |
|
| July 6, 2023 |
EX-4.9 Exhibit 4.9 THIS INSTRUMENT AND THE INDEBTEDNESS EVIDENCED HEREBY ARE SUBORDINATE IN THE MANNER AND TO THE EXTENT SET FORTH IN THAT CERTAIN SUBORDINATION AGREEMENT (AS AMENDED, RESTATED, SUPPLEMENTED OR OTHERWISE MODIFIED FROM TIME TO TIME, THE “SUBORDINATION AGREEMENT”) DATED AS OF JULY 5, 2023, BY AND AMONG ABACUS INVESTMENT SPV, LLC (“SUBORDINATED CREDITOR”), OWL ROCK CAPITAL CORPORATION |
|
| July 6, 2023 |
EX-4.6 Exhibit 4.6 CREDIT AGREEMENT among ABACUS LIFE, INC., as Borrower THE SEVERAL LENDERS FROM TIME TO TIME PARTY HERETO, OWL ROCK CAPITAL CORPORATION, as Administrative Agent and Collateral Agent Dated as of July 5, 2023 OWL ROCK CAPITAL ADVISORS LLC as Lead Arranger and Bookrunner Table of Contents Page SECTION 1. DEFINITIONS 1 1.1 Defined Terms 1 1.2 Other Definitional Provisions 42 1.3 Divi |
|
| July 6, 2023 |
EX-4.4 Exhibit 4.4 THIS UNSECURED SENIOR PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS. THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATI |
|
| July 6, 2023 |
EX-4.10 Exhibit 4.10 THIS INSTRUMENT AND THE INDEBTEDNESS EVIDENCED HEREBY ARE SUBORDINATE IN THE MANNER AND TO THE EXTENT SET FORTH IN THAT CERTAIN SUBORDINATION AGREEMENT (AS AMENDED, RESTATED, SUPPLEMENTED OR OTHERWISE MODIFIED FROM TIME TO TIME, THE “SUBORDINATION AGREEMENT”) DATED AS OF JULY 5, 2023, BY AND AMONG ABACUS INVESTMENT SPV, LLC (“SUBORDINATED CREDITOR”), OWL ROCK CAPITAL CORPORATI |
|
| July 6, 2023 |
EX-99.4 Exhibit 99.4 Abacus Settlements, LLC d/b/a Abacus Life Unaudited Condensed Financial Statements as of March 31, 2023 and December 31, 2022 and for the Three Months Ended March 31, 2023, and 2022 1 ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE TABLE OF CONTENTS Page Unaudited Condensed Financial Statements as of March 31, 2023 and December 31, 2022 and for the Three Months Ended March 31, 2023, |
